PATENT CLAIM ANALYSIS

Application Number: 15747136
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "325000"]

Abstract:
Described herein are gene-activated fibrillar compositions and methods, processes, devices for the design, preparation, manufacture and/or formulation of thereof which are capable to encode at least one polypeptide of interest. Methods treating a disease, disorder and/or condition in a subject by increasing the level of at least one polypeptide of interest, by administering to said subject the gene-activated fibrillar composition are also disclosed.

Claim (Index 8):
A composition of  claim 2 , wherein chemical transfection methods rely on electrostatic interactions to bind nucleic acid and to target cell membranes utilizing compounds such as calcium phosphate, polycations, liposomes, as well as cationic lipids, polymers, dendrimers, nanoparticles, polyethylenimine, and polylysine.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.54348
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13925005', '14351128', '11464184', '12539563', '14369008']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5817005135118026
- 35 USC 102 Novelty (BERT): 0.4905451797997524
- Combined Prediction Score: 0.5725849801405977
- Mean Citation Score: 192.138298
- Max Citation Score: 220.22778
- Similarity Product: 159.92933167399406

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test